Sally Fuess
Impact in
- Genetics top 1%
- Virus-based gene therapy research
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Viral Infectious Diseases and Gene Expression in Insects
- Muscle Physiology and Disorders
Papers in
- Genetics 12
- Virus-based gene therapy research 12
-
- Viral Infections and Immunology Research 5
- Co-authors
- Mark A. KayTheresa A. StormHiroyuki NakaiLeonard MeuseKatsuya InagakiEugenio MontiniStephen R. YantMarkus Grompe
- Journals
- Journal of Virology (5 papers)Molecular Therapy (4 papers)Nature Genetics (1 paper)Human Gene Therapy (1 paper)Hepatology (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Sally Fuess
14 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 77
- Genetics 1.6k
- Molecular Biology 1.7k
- Cardiology and Cardiovascular Medicine 310
- Infectious Diseases 229
- Oncology 275
Countries citing papers authored by Sally Fuess
This map shows the geographic impact of Sally Fuess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Fuess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Fuess more than expected).
Fields of papers citing papers by Sally Fuess
This network shows the impact of papers produced by Sally Fuess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Fuess. The network helps show where Sally Fuess may publish in the future.
Co-authors
The 25 scholars most cited alongside Sally Fuess, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 9 | |
| 2 | 2007 | 72 | |
| 3 | 2007 | 44 | |
| 4 | 2006 | 475 | |
| 5 | 2005 | 140 | |
| 6 | 2004 | 256 | |
| 7 | 2003 | 22 | |
| 8 | 2003 | 294 | |
| 9 | 2003 | 44 | |
| 10 | 2003 | 23 | |
| 11 | 2003 | 178 | |
| 12 | 2002 | 83 | |
| 13 | 2001 | 366 | |
| 14 | 2000 | 151 |
About Sally Fuess
Sally Fuess is a scholar working on Genetics, Cardiology and Cardiovascular Medicine, Infectious Diseases, Hepatology and Molecular Biology, having authored 14 papers that have together received 2.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), RNA Interference and Gene Delivery (6 papers), Viral Infections and Immunology Research (5 papers), CRISPR and Genetic Engineering (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Herpesvirus Infections and Treatments (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Organ Transplantation Techniques and Outcomes (1 paper). The work is most often cited by research in Genetics (1.6k citations), Molecular Biology (1.7k citations), Cardiology and Cardiovascular Medicine (310 citations), Infectious Diseases (229 citations) and Oncology (275 citations). Sally Fuess has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Mark A. Kay, Theresa A. Storm, Hiroyuki Nakai, Leonard Meuse, Katsuya Inagaki, Eugenio Montini, Stephen R. Yant, Markus Grompe, Gregory A. Gibson and Charles F. McTiernan. Their work appears in journals such as Journal of Virology, Molecular Therapy, Nature Genetics, Human Gene Therapy and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.